Kaken Pharmaceutical Co., Ltd. (TYO:4521)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Pharmaceutical Industry		91.55B	69.61B	70.56B	73.62B	72.61B
Pharmaceutical Industry Growth		31.52%	-1.34%	-4.16%	1.39%	-16.39%
Real Estate		2.48B	2.43B	2.42B	2.41B	2.37B
Real Estate Growth		2.10%	0.33%	0.50%	1.90%	-0.55%
Total		94.03B	72.04B	72.98B	76.03B	74.98B
Total Growth		30.52%	-1.29%	-4.01%	1.41%	-15.97%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Japan		94.04B	72.04B	72.98B	76.03B	74.98B
Japan Growth		30.52%	-1.29%	-4.01%	1.41%	-15.97%
Total		94.04B	72.04B	72.98B	76.03B	74.98B
Total Growth		30.52%	-1.29%	-4.01%	1.41%	-15.97%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 14, 2026

Data Sources Report a data error